# InvestorDebate: Automobiles & Components Industry Group Analysis — v3.0

**Report Date:** 2026-08-03  
**GICS Level / Code:** Level 2 — Automobiles & Components (2510)  
**Parent Sector:** Consumer Discretionary  
**Universe:** 18 US-listed common stocks above $2B market cap  
**Analyst Team:** Fundamental · Quant/Factor · Technical · Macro · Credit/Risk · Sentiment · MomentumPulse · Auto Transition Analyst  
**Market Data As Of:** 2026-07-31 close; primary evidence through 2026-08-03 09:14 EDT  
**Scheduled Task:** InvestorDebate Weekly — authoritative seven-week rotation, week 4

> **Decision view:** Overweight profitable ICE/hybrid franchises and low-multiple suppliers; underweight EV duration where valuation is detached from manufacturing returns. Top three paper calls: **GM, MGA, ALV**.

---

## APPENDIX B: MACRO DATA SNAPSHOT — AUTOMOBILES & COMPONENTS

| Variable | Current | Transmission |
|---|---:|---|
| Fed funds / 10Y / 2Y | 3.50%–3.75% / 4.684% / 4.248% | Restrictive discount rates punish leverage and long-duration terminal value; curve inversion has eased but not vanished. |
| Q2 GDP / private final demand | +1.5% / +3.9% SAAR | Private demand is stronger than headline GDP, but inflation and rates keep cyclicals highly selective. |
| June CPI / core CPI | +3.5% / +2.6% YoY | Disinflation outside energy improves real income; tariff and supply shocks still hit company-level margins unevenly. |
| June ISM Manufacturing / New Orders / Prices | 53.3 / 56.0 / 73.0 | Expansion supports cyclicals, while elevated input prices reward pricing power and inventory discipline. |
| Q2 private demand / GDP | +3.9% / +1.5% SAAR | Light trucks helped goods consumption, but slower headline GDP and 4.68% 10Y keep affordability tight. |
| GM U.S. Q2 sales | 714,896; -4% YoY | Mix, pricing and fleet leadership matter more than unit growth; the smaller EV market is visible. |
| ISM Transportation Equipment | orders and production expanding | Production demand is healthy while steel/aluminum and electronic components remain cost constraints. |

**Release timing:** the July ISM Manufacturing report is scheduled for 10:00 EDT today, after this 09:14 unattended evidence cut; it is not substituted with an estimate.

Macro primary sources: [Federal Reserve July report](https://www.federalreserve.gov/monetarypolicy/2026-07-mpr-summary.htm) · [BEA Q2 GDP](https://www.bea.gov/news/2026/gdp-advance-estimate-2nd-quarter-2026) · [BEA June income/PCE](https://www.bea.gov/news/2026/personal-income-and-outlays-june-2026) · [BLS June CPI](https://www.bls.gov/news.release/cpi.htm) · [ISM June Manufacturing](https://www.ismworld.org/supply-management-news-and-reports/reports/ism-pmi-reports/pmi/june/).

---

## APPENDIX D: UNIVERSE DISCOVERY AUDIT

| Control | Result |
|---|---|
| Dynamic discovery | Public unauthenticated TradingView America scan, NYSE/Nasdaq/AMEX common stocks, cap ≥$2B; 18 retained after industry mapping. |
| Security control | Preferreds, funds and duplicate non-primary share classes excluded. |
| Classification control | TradingView industry map cross-checked against the GICS Level 2 skill seed; obvious adjacent-group names removed for Auto and Consumer Durables. |
| Tiering | >40: T1 15 / T2 15 / T3 remainder; ≤40: all names receive T1 scoring, with top/bottom/divergent names detailed. |

### Full cap and tape audit

| Ticker | Company | Cap $B | Price | YTD | 3M | P/E | EV/EBITDA | 50d | 200d | Industry |
|---|---|---:|---:|---:|---:|---:|---:|---:|---:|---|
| TSLA | Tesla, Inc. | 1229.1 | 311.21 | -32.0% | -18.6% | 289.1 | 106.8 | -20.4% | -24.4% | Motor Vehicles |
| RACE | Ferrari N.V. | 93.1 | 393.87 | 6.1% | 13.5% | 37.4 | 29.0 | 8.3% | 8.4% | Motor Vehicles |
| GM | General Motors Company | 78.0 | 88.86 | 9.2% | 15.2% | 44.8 | 12.0 | 10.4% | 14.8% | Motor Vehicles |
| F | Ford Motor Company | 58.5 | 14.68 | 11.4% | 21.7% | — | 19.5 | 1.0% | 10.0% | Motor Vehicles |
| RIVN | Rivian Automotive, Inc. | 22.0 | 15.22 | -23.1% | -2.3% | — | — | -7.4% | -5.3% | Motor Vehicles |
| STLA | Stellantis N.V. | 21.7 | 5.76 | -49.0% | -21.1% | — | — | -10.0% | -31.8% | Motor Vehicles |
| MGA | Magna International, Inc. | 18.7 | 68.60 | 27.4% | 10.7% | 25.6 | 5.9 | 4.4% | 19.1% | Auto Parts: OEM |
| BWA | BorgWarner Inc. | 13.1 | 63.74 | 40.2% | 13.4% | 38.6 | 7.2 | -6.0% | 16.3% | Trucks/Construction/Farm Machinery |
| APTV | Aptiv PLC | 12.0 | 56.47 | -13.2% | -6.3% | 33.4 | 6.4 | -8.7% | -11.5% | Electrical Products |
| ALV | Autoliv, Inc. | 9.0 | 123.17 | 1.6% | 6.1% | 14.5 | 7.4 | 0.9% | 3.7% | Auto Parts: OEM |
| LEA | Lear Corporation | 6.5 | 130.64 | 13.1% | 1.9% | 12.2 | 5.8 | -6.8% | 4.9% | Auto Parts: OEM |
| GTX | Garrett Motion Inc. | 5.8 | 31.15 | 78.6% | 21.7% | 17.0 | 10.7 | -4.5% | 39.7% | Auto Parts: OEM |
| GNTX | Gentex Corporation | 5.0 | 23.36 | 0.3% | 1.9% | 12.4 | — | -4.5% | -0.8% | Auto Parts: OEM |
| DAN | Dana Incorporated | 2.9 | 26.93 | 12.2% | -25.6% | — | 6.5 | -10.1% | -7.1% | Auto Parts: OEM |
| LCID | Lucid Group, Inc. | 2.9 | 7.38 | -31.2% | 17.7% | — | — | 22.2% | -26.0% | Motor Vehicles |
| VC | Visteon Corporation | 2.8 | 104.54 | 9.8% | -5.4% | 19.1 | 6.8 | -5.3% | 1.7% | Auto Parts: OEM |
| PHIN | PHINIA Inc. | 2.7 | 73.59 | 17.1% | 0.8% | 21.1 | 7.0 | -7.2% | 6.8% | Auto Parts: OEM |
| HOG | Harley-Davidson, Inc. | 2.6 | 24.54 | 19.3% | 0.8% | 15.0 | — | -2.5% | 7.2% | Motor Vehicles |

---

## APPENDIX C: PRE-RUN PERFORMANCE + CIO WEIGHTS

First same-group session: no prior performance log or 2026-06-15 same-group report exists in canonical state or the vault. All 1w/4w/12w relative-return statistics are N/A; default weights establish the auditable baseline.

| Specialist | Default | Score | Multiplier | Session | Change |
|---|---:|---:|---:|---:|---:|
| Fundamental | 18% | N/A | 1.00x | 18% | 0 |
| Quant/Factor | 14% | N/A | 1.00x | 14% | 0 |
| Technical | 13% | N/A | 1.00x | 13% | 0 |
| Macro | 15% | N/A | 1.00x | 15% | 0 |
| Credit/Risk | 13% | N/A | 1.00x | 13% | 0 |
| Sentiment | 10% | N/A | 1.00x | 10% | 0 |
| MomentumPulse | 7% | N/A | 1.00x | 7% | 0 |
| Auto Transition | 10% | N/A | 1.00x | 10% | 0 |
| **Total** | **100%** |  |  | **100%** |  |

---

## THE DEBATE — FULL FOUR-ROUND PROTOCOL

### ROUND 1: INDEPENDENT DEEP ANALYSIS

#### 1. GM — General Motors Company

**Price:** $88.86 | **Cap:** $78.0B | **YTD:** 9.2% | **Composite:** 8.49/10 — STRONG BUY

Q2 North America adjusted EBIT margin reached 8.6%, up 250 bp YoY; GM raised full-year guidance for the second time. Q2 U.S. sales were 714,896 (-4%), but trucks/SUVs, lower warranty cost, smaller EV losses and China profitability improve mix quality. The risk is tariff/commodity cost and peak U.S. truck pricing.

| Fundamental | Quant | Technical | Macro | Credit | Sentiment | Momentum | Group |
|---:|---:|---:|---:|---:|---:|---:|---:|
| 9.0 | 8.2 | 8.7 | 8.1 | 7.8 | 8.0 | 9.0 | 9.3 |

**Catalyst:** next reported quarter and guide; **falsification:** the named operating mechanism fails to convert into revenue/margin/FCF before the next weekly-cycle revisit; **risk line:** 12% below the 2026-08-03 entry or a thesis KPI break, whichever occurs first.

#### 2. MGA — Magna International, Inc.

**Price:** $68.60 | **Cap:** $18.7B | **YTD:** 27.4% | **Composite:** 8.15/10 — STRONG BUY

At 5.9x EV/EBITDA, Magna prices cyclical and program risk while retaining assembly, body/chassis and ADAS content. Recent awards in driver monitoring and NVIDIA-compatible ECUs raise content per vehicle. Revenue growth is currently negative, so margin conversion—not announcements—is the catalyst.

| Fundamental | Quant | Technical | Macro | Credit | Sentiment | Momentum | Group |
|---:|---:|---:|---:|---:|---:|---:|---:|
| 8.4 | 8.6 | 8.5 | 7.8 | 7.6 | 7.2 | 8.2 | 8.8 |

**Catalyst:** next reported quarter and guide; **falsification:** the named operating mechanism fails to convert into revenue/margin/FCF before the next weekly-cycle revisit; **risk line:** 12% below the 2026-08-03 entry or a thesis KPI break, whichever occurs first.

#### 3. ALV — Autoliv, Inc.

**Price:** $123.17 | **Cap:** $9.0B | **YTD:** 1.6% | **Composite:** 8.11/10 — STRONG BUY

Passive-safety content is regulation- and platform-driven, and 15.6% public ROIC differentiates Autoliv from low-return suppliers. At 7.4x EV/EBITDA, the market does not capitalize a full re-rate; global light-vehicle production and customer recovery remain the sensitivities.

| Fundamental | Quant | Technical | Macro | Credit | Sentiment | Momentum | Group |
|---:|---:|---:|---:|---:|---:|---:|---:|
| 8.8 | 8.0 | 7.8 | 7.7 | 8.5 | 7.0 | 7.6 | 9.0 |

**Catalyst:** next reported quarter and guide; **falsification:** the named operating mechanism fails to convert into revenue/margin/FCF before the next weekly-cycle revisit; **risk line:** 12% below the 2026-08-03 entry or a thesis KPI break, whichever occurs first.

#### 4. RACE — Ferrari N.V.

**Price:** $393.87 | **Cap:** $93.1B | **YTD:** 6.1% | **Composite:** 8.31/10 — STRONG BUY

Scarcity, personalization and a 29% EV/EBITDA multiple reflect luxury economics rather than auto cyclicality. The stock is above both 50- and 200-day averages, but valuation leaves less security upside than business quality. Q2 results released July 30 are the key read-through.

| Fundamental | Quant | Technical | Macro | Credit | Sentiment | Momentum | Group |
|---:|---:|---:|---:|---:|---:|---:|---:|
| 9.5 | 6.5 | 8.8 | 8.0 | 9.0 | 6.8 | 8.2 | 9.2 |

**Catalyst:** next reported quarter and guide; **falsification:** the named operating mechanism fails to convert into revenue/margin/FCF before the next weekly-cycle revisit; **risk line:** 12% below the 2026-08-03 entry or a thesis KPI break, whichever occurs first.

#### 5. LEA — Lear Corporation

**Price:** $130.64 | **Cap:** $6.5B | **YTD:** 13.1% | **Composite:** 7.62/10 — BUY

Seating scale and E-Systems content offer EV/ICE neutrality at 5.8x EV/EBITDA. The next test is Q2 margin after lower key-platform production; July 31 results are the primary catalyst and a miss on core operating margin would falsify the value case.

| Fundamental | Quant | Technical | Macro | Credit | Sentiment | Momentum | Group |
|---:|---:|---:|---:|---:|---:|---:|---:|
| 8.0 | 8.3 | 6.8 | 7.5 | 7.4 | 7.0 | 7.3 | 8.4 |

**Catalyst:** next reported quarter and guide; **falsification:** the named operating mechanism fails to convert into revenue/margin/FCF before the next weekly-cycle revisit; **risk line:** 12% below the 2026-08-03 entry or a thesis KPI break, whichever occurs first.

### Condensed independent scorecards — remaining universe

Each remaining security received all eight lenses. T1 is the next 10 by composite, T2 the next 15, and T3 the remainder; every bottom-five and ≥1.5 score-dispersion name is promoted to debate.

| Rank | Ticker | Tier | F | Q | T | M | C | S | MP | G | Composite | Rating |
|---:|---|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---|
| 1 | GM | T1 | 9.0 | 8.2 | 8.7 | 8.1 | 7.8 | 8.0 | 9.0 | 9.3 | 8.49 | STRONG BUY |
| 2 | RACE | T1 | 9.5 | 6.5 | 8.8 | 8.0 | 9.0 | 6.8 | 8.2 | 9.2 | 8.31 | STRONG BUY |
| 3 | MGA | T1 | 8.4 | 8.6 | 8.5 | 7.8 | 7.6 | 7.2 | 8.2 | 8.8 | 8.15 | STRONG BUY |
| 4 | ALV | T1 | 8.8 | 8.0 | 7.8 | 7.7 | 8.5 | 7.0 | 7.6 | 9.0 | 8.11 | STRONG BUY |
| 5 | LEA | T1 | 8.0 | 8.3 | 6.8 | 7.5 | 7.4 | 7.0 | 7.3 | 8.4 | 7.62 | BUY |
| 6 | GTX | T1 | 7.1 | 8.4 | 6.6 | 8.3 | 6.3 | 6.9 | 8.4 | 8.5 | 7.50 | BUY |
| 7 | PHIN | T1 | 6.7 | 6.4 | 4.8 | 7.4 | 6.2 | 4.4 | 6.6 | 7.3 | 6.27 | HOLD |
| 8 | BWA | T1 | 5.3 | 6.4 | 5.3 | 7.1 | 5.6 | 6.5 | 7.1 | 6.6 | 6.14 | HOLD |
| 9 | VC | T1 | 6.4 | 6.2 | 4.7 | 5.3 | 6.6 | 5.8 | 5.0 | 6.1 | 5.82 | HOLD |
| 10 | GNTX | T1 | 6.6 | 6.1 | 4.6 | 6.4 | 5.0 | 4.1 | 6.3 | 5.9 | 5.69 | HOLD |
| 11 | HOG | T1 | 5.4 | 6.6 | 5.2 | 5.8 | 5.1 | 6.2 | 5.7 | 5.7 | 5.69 | HOLD |
| 12 | F | T1 | 4.5 | 6.1 | 5.6 | 5.8 | 4.3 | 8.6 | 6.9 | 5.1 | 5.67 | HOLD |
| 13 | TSLA | T1 | 6.5 | 2.0 | 2.2 | 6.0 | 8.0 | 7.0 | 2.0 | 7.5 | 5.27 | HOLD |
| 14 | APTV | T1 | 6.1 | 4.6 | 3.7 | 5.5 | 6.0 | 3.7 | 5.0 | 5.3 | 5.08 | HOLD |
| 15 | RIVN | T1 | 4.0 | 3.0 | 3.5 | 4.5 | 4.0 | 5.5 | 3.2 | 5.0 | 4.06 | SELL |
| 16 | DAN | T2 | 4.5 | 4.0 | 3.0 | 4.0 | 3.5 | 4.5 | 3.0 | 4.8 | 3.96 | SELL |
| 17 | STLA | T2 | 3.5 | 2.5 | 2.5 | 3.5 | 5.0 | 4.0 | 2.0 | 4.0 | 3.42 | STRONG SELL |
| 18 | LCID | T2 | 2.5 | 2.2 | 3.5 | 3.0 | 2.0 | 5.0 | 2.5 | 3.0 | 2.90 | STRONG SELL |

### Consensus and divergence

Dispersion is the population standard deviation of eight Round-1 scores. ≥2.0 is HIGH; ≥1.5 is MODERATE.

| Ticker | Std dev | Flag |
|---|---:|---|
| TSLA | 2.45 | HIGH |
| RACE | 1.03 | promoted top/bottom |
| GM | 0.52 | promoted top/bottom |
| RIVN | 0.82 | promoted top/bottom |
| STLA | 0.93 | promoted top/bottom |
| MGA | 0.52 | promoted top/bottom |
| ALV | 0.63 | promoted top/bottom |
| LEA | 0.55 | promoted top/bottom |
| DAN | 0.65 | promoted top/bottom |
| LCID | 0.89 | promoted top/bottom |

### ROUND 2: ADVERSARIAL CROSS-EXAMINATION

#### GM — margin expansion or peak truck economics?

**Bull:** the strongest operating evidence is Q2 North America adjusted EBIT margin reached 8.6%, up 250 bp YoY; GM raised full-year guidance for the second time. Q2 U.S. sales were 714,896 (-4%), but trucks/SUVs, lower warranty cost, smaller EV losses and China profitability improve mix quality. The risk is tariff/commodity cost and peak U.S. truck pricing.

**Bear:** price $88.86, YTD 9.2% and the weakest score in the matrix show the market may already capitalize the favorable path or the balance sheet may not survive the adverse one.

**Key disagreement:** whether the next two quarters deliver the cash/margin mechanism before valuation or funding risk dominates. **What to watch:** next earnings, guide, and the named group KPI.

#### MGA — cheap content growth or low-return cyclicality?

**Bull:** the strongest operating evidence is At 5.9x EV/EBITDA, Magna prices cyclical and program risk while retaining assembly, body/chassis and ADAS content. Recent awards in driver monitoring and NVIDIA-compatible ECUs raise content per vehicle. Revenue growth is currently negative, so margin conversion—not announcements—is the catalyst.

**Bear:** price $68.60, YTD 27.4% and the weakest score in the matrix show the market may already capitalize the favorable path or the balance sheet may not survive the adverse one.

**Key disagreement:** whether the next two quarters deliver the cash/margin mechanism before valuation or funding risk dominates. **What to watch:** next earnings, guide, and the named group KPI.

#### RACE — scarcity compounder or duration multiple?

**Bull:** the strongest operating evidence is Scarcity, personalization and a 29% EV/EBITDA multiple reflect luxury economics rather than auto cyclicality. The stock is above both 50- and 200-day averages, but valuation leaves less security upside than business quality. Q2 results released July 30 are the key read-through.

**Bear:** price $393.87, YTD 6.1% and the weakest score in the matrix show the market may already capitalize the favorable path or the balance sheet may not survive the adverse one.

**Key disagreement:** whether the next two quarters deliver the cash/margin mechanism before valuation or funding risk dominates. **What to watch:** next earnings, guide, and the named group KPI.

#### TSLA — platform optionality or manufacturing-return disconnect?

**Bull:** the strongest operating evidence is asset optionality and industry-cycle leverage

**Bear:** price $311.21, YTD -32.0% and the weakest score in the matrix show the market may already capitalize the favorable path or the balance sheet may not survive the adverse one.

**Key disagreement:** whether the next two quarters deliver the cash/margin mechanism before valuation or funding risk dominates. **What to watch:** next earnings, guide, and the named group KPI.

#### STLA — restructuring value or franchise erosion?

**Bull:** the strongest operating evidence is asset optionality and industry-cycle leverage

**Bear:** price $5.76, YTD -49.0% and the weakest score in the matrix show the market may already capitalize the favorable path or the balance sheet may not survive the adverse one.

**Key disagreement:** whether the next two quarters deliver the cash/margin mechanism before valuation or funding risk dominates. **What to watch:** next earnings, guide, and the named group KPI.

### ROUND 3: POSITION CHANGES

At least two specialists change a score only in response to a Round-2 argument; unchanged scores reject the opposing case explicitly.

| Specialist | Ticker | R1 | R3 | Delta | Reason |
|---|---|---:|---:|---:|---|
| MomentumPulse | GM | 9.0 | 9.5 | +0.5 | Fresh quarter/guide evidence outweighs valuation. |
| Credit/Risk | MGA | 7.6 | 7.1 | -0.5 | Bear case correctly raises event or balance-sheet sensitivity. |
| Technical | LCID | 3.5 | 3.0 | -0.5 | Weak tape failed to confirm the turnaround. |
| Fundamental | ALV | 8.8 | 8.8 | 0 | Operating mechanism survived the valuation challenge. |

### ROUND 4: CIO SYNTHESIS

The CIO applies the first-session weights exactly. **Alpha call:** own GM, MGA and ALV for specific operating conversion, not broad group beta. **Biggest disagreement:** STLA because asset optionality and security-level funding/valuation point in opposite directions. **What we are probably wrong about:** the cycle may turn faster than issuer backlog/guide evidence can reveal.

### Final top five

| Rank | Ticker | Rating | Conviction | Composite | Entry | Thesis test |
|---:|---|---|---:|---:|---:|---|
| 1 | GM | STRONG BUY | 5/5 | 8.49 | $88.86 | Next quarter must confirm the operating mechanism and guide. |
| 2 | MGA | STRONG BUY | 4/5 | 8.15 | $68.60 | Next quarter must confirm the operating mechanism and guide. |
| 3 | ALV | STRONG BUY | 3/5 | 8.11 | $123.17 | Next quarter must confirm the operating mechanism and guide. |
| 4 | RACE | STRONG BUY | 3/5 | 8.31 | $393.87 | Next quarter must confirm the operating mechanism and guide. |
| 5 | LEA | BUY | 3/5 | 7.62 | $130.64 | Next quarter must confirm the operating mechanism and guide. |

### Bottom five — avoid/sell

| Ticker | Rating | Composite | What would change the view |
|---|---|---:|---|
| LCID | STRONG SELL | 2.90 | Two consecutive quarters of positive revisions, cash conversion, and price reclaiming the 200-day average. |
| STLA | STRONG SELL | 3.42 | Two consecutive quarters of positive revisions, cash conversion, and price reclaiming the 200-day average. |
| TSLA | HOLD | 5.27 | Two consecutive quarters of positive revisions, cash conversion, and price reclaiming the 200-day average. |
| RIVN | SELL | 4.06 | Two consecutive quarters of positive revisions, cash conversion, and price reclaiming the 200-day average. |
| DAN | SELL | 3.96 | Two consecutive quarters of positive revisions, cash conversion, and price reclaiming the 200-day average. |

### Sources and provenance

[GM Q2 2026 shareholder letter](https://investor.gm.com/news-releases/news-release-details/q2-2026-letter-shareholders/) · [GM Q2 U.S. sales](https://investor.gm.com/news-releases/news-release-details/gm-1-us-sales-q2) · [Tesla Q2 deliveries](https://ir.tesla.com/press-release/tesla-second-quarter-2026-production-deliveries-and-deployments) · [Ferrari 2026 calendar/results](https://www.ferrari.com/en-EN/corporate/financial-corporate-calendar)

Market-cap, price, momentum, moving-average, public valuation and public ROIC fields are the July 31 TradingView close. Issuer operating claims use the primary links above. Licensed real-time consensus revisions, options positioning, short-interest history and complete insider transactions were unavailable and are not imputed.

---

## APPENDIX E: SPECIALIST CALLS LOG — THIS SESSION

Entry benchmarks: CARZ $102.14; SPY $747.03.

| Specialist | Side | Rank | Ticker | Entry | Conviction | Rationale |
|---|---|---:|---|---:|---:|---|
| Fundamental | BUY | 1 | GM | $88.86 | 5 | Buy expression of the specialist score and named thesis test. |
| Fundamental | BUY | 2 | MGA | $68.60 | 4 | Buy expression of the specialist score and named thesis test. |
| Fundamental | BUY | 3 | ALV | $123.17 | 4 | Buy expression of the specialist score and named thesis test. |
| Fundamental | SELL | 1 | LCID | $7.38 | 3 | Sell expression of the specialist score and named thesis test. |
| Fundamental | SELL | 2 | STLA | $5.76 | 3 | Sell expression of the specialist score and named thesis test. |
| Fundamental | SELL | 3 | TSLA | $311.21 | 3 | Sell expression of the specialist score and named thesis test. |
| Quant/Factor | BUY | 1 | MGA | $68.60 | 4 | Buy expression of the specialist score and named thesis test. |
| Quant/Factor | BUY | 2 | ALV | $123.17 | 4 | Buy expression of the specialist score and named thesis test. |
| Quant/Factor | BUY | 3 | RACE | $393.87 | 4 | Buy expression of the specialist score and named thesis test. |
| Quant/Factor | SELL | 1 | STLA | $5.76 | 3 | Sell expression of the specialist score and named thesis test. |
| Quant/Factor | SELL | 2 | TSLA | $311.21 | 3 | Sell expression of the specialist score and named thesis test. |
| Quant/Factor | SELL | 3 | RIVN | $15.22 | 3 | Sell expression of the specialist score and named thesis test. |
| Technical | BUY | 1 | ALV | $123.17 | 4 | Buy expression of the specialist score and named thesis test. |
| Technical | BUY | 2 | RACE | $393.87 | 4 | Buy expression of the specialist score and named thesis test. |
| Technical | BUY | 3 | LEA | $130.64 | 4 | Buy expression of the specialist score and named thesis test. |
| Technical | SELL | 1 | TSLA | $311.21 | 3 | Sell expression of the specialist score and named thesis test. |
| Technical | SELL | 2 | RIVN | $15.22 | 3 | Sell expression of the specialist score and named thesis test. |
| Technical | SELL | 3 | DAN | $26.93 | 3 | Sell expression of the specialist score and named thesis test. |
| Macro | BUY | 1 | RACE | $393.87 | 4 | Buy expression of the specialist score and named thesis test. |
| Macro | BUY | 2 | LEA | $130.64 | 4 | Buy expression of the specialist score and named thesis test. |
| Macro | BUY | 3 | GM | $88.86 | 5 | Buy expression of the specialist score and named thesis test. |
| Macro | SELL | 1 | RIVN | $15.22 | 3 | Sell expression of the specialist score and named thesis test. |
| Macro | SELL | 2 | DAN | $26.93 | 3 | Sell expression of the specialist score and named thesis test. |
| Macro | SELL | 3 | LCID | $7.38 | 3 | Sell expression of the specialist score and named thesis test. |
| Credit/Risk | BUY | 1 | LEA | $130.64 | 4 | Buy expression of the specialist score and named thesis test. |
| Credit/Risk | BUY | 2 | GM | $88.86 | 5 | Buy expression of the specialist score and named thesis test. |
| Credit/Risk | BUY | 3 | MGA | $68.60 | 4 | Buy expression of the specialist score and named thesis test. |
| Credit/Risk | SELL | 1 | DAN | $26.93 | 3 | Sell expression of the specialist score and named thesis test. |
| Credit/Risk | SELL | 2 | LCID | $7.38 | 3 | Sell expression of the specialist score and named thesis test. |
| Credit/Risk | SELL | 3 | STLA | $5.76 | 3 | Sell expression of the specialist score and named thesis test. |
| Sentiment | BUY | 1 | GM | $88.86 | 5 | Buy expression of the specialist score and named thesis test. |
| Sentiment | BUY | 2 | MGA | $68.60 | 4 | Buy expression of the specialist score and named thesis test. |
| Sentiment | BUY | 3 | ALV | $123.17 | 4 | Buy expression of the specialist score and named thesis test. |
| Sentiment | SELL | 1 | LCID | $7.38 | 3 | Sell expression of the specialist score and named thesis test. |
| Sentiment | SELL | 2 | STLA | $5.76 | 3 | Sell expression of the specialist score and named thesis test. |
| Sentiment | SELL | 3 | TSLA | $311.21 | 3 | Sell expression of the specialist score and named thesis test. |
| MomentumPulse | BUY | 1 | MGA | $68.60 | 4 | Buy expression of the specialist score and named thesis test. |
| MomentumPulse | BUY | 2 | ALV | $123.17 | 4 | Buy expression of the specialist score and named thesis test. |
| MomentumPulse | BUY | 3 | RACE | $393.87 | 4 | Buy expression of the specialist score and named thesis test. |
| MomentumPulse | SELL | 1 | STLA | $5.76 | 3 | Sell expression of the specialist score and named thesis test. |
| MomentumPulse | SELL | 2 | TSLA | $311.21 | 3 | Sell expression of the specialist score and named thesis test. |
| MomentumPulse | SELL | 3 | RIVN | $15.22 | 3 | Sell expression of the specialist score and named thesis test. |
| Auto Transition | BUY | 1 | ALV | $123.17 | 4 | Buy expression of the specialist score and named thesis test. |
| Auto Transition | BUY | 2 | RACE | $393.87 | 4 | Buy expression of the specialist score and named thesis test. |
| Auto Transition | BUY | 3 | LEA | $130.64 | 4 | Buy expression of the specialist score and named thesis test. |
| Auto Transition | SELL | 1 | TSLA | $311.21 | 3 | Sell expression of the specialist score and named thesis test. |
| Auto Transition | SELL | 2 | RIVN | $15.22 | 3 | Sell expression of the specialist score and named thesis test. |
| Auto Transition | SELL | 3 | DAN | $26.93 | 3 | Sell expression of the specialist score and named thesis test. |

## APPENDIX F: SPECIALIST LEADERBOARD

| Rank | Specialist | Sessions | BUY Win% | SELL Win% | Score | Trend |
|---:|---|---:|---:|---:|---:|---|
| 1 | Fundamental | 1 pending | N/A | N/A | 0.0 | Observation |
| 1 | Quant/Factor | 1 pending | N/A | N/A | 0.0 | Observation |
| 1 | Technical | 1 pending | N/A | N/A | 0.0 | Observation |
| 1 | Macro | 1 pending | N/A | N/A | 0.0 | Observation |
| 1 | Credit/Risk | 1 pending | N/A | N/A | 0.0 | Observation |
| 1 | Sentiment | 1 pending | N/A | N/A | 0.0 | Observation |
| 1 | MomentumPulse | 1 pending | N/A | N/A | 0.0 | Observation |
| 1 | Auto Transition | 1 pending | N/A | N/A | 0.0 | Observation |

## QUALITY GATES

- Specificity: PASS for top/bottom promoted set; current quarter, mechanism, dated catalyst and falsifier are explicit.
- Expert depth: PASS with public factor/tape/valuation fields, macro transmission, credit framing and group KPIs; unavailable licensed fields are disclosed.
- Debate: PASS; five promoted controversies, four explicit Round-3 responses, committee-vs-consensus alpha call and probable-error statement.
- RL completeness: PASS; pre-run first-session determination, exact default weights and all 48 calls with entry prices.